Goldman Sachs’s SCP & CO Healthcare Acquisition Company Class A Common Stock SHAC Stock Holding History

Goldman Sachs’s Portfolio SHAC Stock Details SHAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-325,140	Closed	-$3.21M	–	6523
2022 Q3	$3.21M	Sell	325,140 -434,535	-57%	-$4.28M	﹤0.01%	3544
2022 Q2	$7.44M	Hold	759,675	–	–	﹤0.01%	2777
2022 Q1	$7.43M	Hold	759,675	–	–	﹤0.01%	2982
2021 Q4	$7.45M	Hold	759,675	–	–	﹤0.01%	3040
2021 Q3	$7.39M	Hold	759,675	–	–	﹤0.01%	3007
2021 Q2	$7.35M	Buy	759,675 +572,953	+307%	+$5.57M	﹤0.01%	2995
2021 Q1	$1.8M	Buy	+186,722	New	+$1.81M	﹤0.01%	4097

Goldman Sachs's SHAC Position: Q4 2022 in Review

Goldman Sachs sold out of SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) in Q4 2022, closing a stake of 325,140 shares — an estimated $3.21M sold.

Goldman Sachs first reported a position in SHAC in Q1 2021 and held it in 7 quarters. The position peaked at $7.45M in Q4 2021. 0 funds tracked by Wall St. Rank hold SHAC as of Q4 2022.

Goldman Sachs reported no remaining SCP & CO Healthcare Acquisition Company Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Goldman Sachs sold 325,140 SCP & CO Healthcare Acquisition Company Class A Common Stock shares in Q4 2022, an estimated $3.21M.
Goldman Sachs first reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock in Q1 2021 and held it in 7 quarters.
Goldman Sachs's SCP & CO Healthcare Acquisition Company Class A Common Stock position peaked at $7.45M in Q4 2021.
0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Class A Common Stock as of Q4 2022.

Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.